Acadia Healthcare (NASDAQ:ACHC) Announces Earnings Results, Beats Estimates By $0.04 EPS

Acadia Healthcare (NASDAQ:ACHC) posted its quarterly earnings data on Wednesday. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04, Briefing.com reports. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same period in the previous year, the firm posted $0.75 EPS. Acadia Healthcare’s revenue was up 9.1% compared to the same quarter last year. Acadia Healthcare updated its FY24 guidance to $3.40-3.70 EPS and its FY 2024 guidance to 3.400-3.700 EPS.

Acadia Healthcare Stock Performance

NASDAQ ACHC traded down $4.76 on Thursday, reaching $68.23. The stock had a trading volume of 630,731 shares, compared to its average volume of 571,479. Acadia Healthcare has a 12-month low of $66.49 and a 12-month high of $87.77. The business’s 50-day moving average price is $77.49 and its 200 day moving average price is $77.68. The stock has a market cap of $6.31 billion, a P/E ratio of -273.23, a price-to-earnings-growth ratio of 2.18 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

ACHC has been the subject of several research reports. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. TD Cowen boosted their price target on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Barclays dropped their target price on Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a research report on Friday, January 5th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $91.00.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.